Title: Air Pollutants and Asthma Control
1Air Pollutants and Asthma Control
www.woolcock.org.au
2Outcomes Investigated
- Short-term effects on symptoms, lung function and
AHR (specific and non-specific) - Chamber studies RCTs
- Panel studies cohort design
- Short-term effects on exacerbations
- ED attendances, hospital admissions, mortality
- Time series
- Long-term effects on asthma incidence, lung
function - Ecological studies
3Pollutants Investigated
- Ozone (oxidants)
- Oxides of nitrogen (mainly NO2)
- Sulphur dioxide
- Particulates (of various sizes)
4Ozone
- Secondary pollutant
- NOx VOC sun time ozone
- Mainly summer afternoons, outdoor
- Insoluble, highly reactive oxidant
- Respirable to small airways and alveoli
5Ozone
- Symptoms
- Cough
- Pain on inspiration
- Chest tightness
- Lung function
- Decrease in lung volumes
- Decrease exercise capacity (athletes)
- Possible enhanced response to allergen challenge
(at high levels)
6Effect of ozone exposureProportion experiencing
gt 10 decrease in FEV1
50
40
30
6.6
6.6
5.6
5.6
20
4.6
4.6
10
Duration(hrs)
3
3
2
2
0
1
1
0.0
0.08
0.1
0.12
Ozone concentration(ppm)
McDonnell et al., AJRCCM 1995 152589-96
7Probability of a 10 Fall in FEV1
8OzoneSummary of Panel Studies (1985 1995)
1
0
Regression coefficient (FEV1 L/ppm)
Mean 0.65 L/ppm
-1
-2
9OzoneFactors influencing response
- concentration
- duration of exposure
- level of exercise
- Marked inter-individual variability, but
consistent within individuals
10OzonePopulation sub-groups
- elite athletes - more responsive
- children less symptoms
- elderly less responsive
- asthma - in general, not different
- COPD - less responsive
11Effect of Ozone on Allergen Responsiveness
Mild atopic asthma (n15) pre-exposed to FA or O3
0.12ppm x 1 hour
Also no significant effect of O3 pre-exposure on
allergen induced increase in non-specific AHR
P 0.12
12Effect of Oxidants on Allergen Responsiveness
No effect at half conc for 6 hrs
3 hour exposure
0.2ppm
0.4ppm
13Effect of Ozone on Post-allergen Sputum Cell
Counts
Mild asthma, dual allergen responders (n 12),
Rx ß2 agonists only
14Differential Cell Counts
FA
O3
15Asthma Admissions
16Ozone and Asthma Admissions Brisbane
17Ozone Dose-Response 1 hr averages
18Ozone Dose-Response 8 hr averages
19OzoneSummary
- Symptoms and decreased lung function
- Dose, duration and exercise dependent
- Athletes most at risk
- Effect in high risk groups not enhanced
- Effect on risk of hospitalisation varies
- Basis of heterogeneity is unknown but may be
informative
20Nitrogen Dioxide
- Fossil fuel combustion
- Motor vehicles
- Gas heaters and stoves
- Poorly soluble, highly reactive oxidant
- Reaches small airways
21Effects of NO2 in People With Asthma
- People with asthma are more sensitive to effects
on airway narrowing - Inter-subject variability
- Some enhanced allergen responsiveness at high
concentrations - Epidemiological evidence of link with asthma
symptoms and hospitalisations is conflicting and
inconclusive - More evidence for link with symptoms with indoor
exposure
22Sydney Air Pollution Study
23Particulates
- Non-gaseous airborne pollutants
- Heterogeneous
- Size matters
- Composition
- Diesel exhaust particulates modulate immune
response in the lung - ? Metals as catalysts
- ? Carrier
- ? Other toxic effect
24Effect of Particulates on Lung FunctionMeta-analy
sis of Panels of Children
25ParticulatesSymptoms and lung function
LRT Symptoms
PEF change (L/min)
PM10 Quartiles
Pope and Dockery, 1992
26ParticulatesEffect on lung function in school
children
0.02
0.01
0.00
-0.01
asthma
Regression coefficient
non-asthma
-0.02
-0.03
-0.04
-0.05
-0.06
Koenig et al., Environ Res 1993 6326-38
27ParticulatesER visits for asthma
Schwartz, 95
28Particulates Acute Exposure in People With Asthma
- More symptoms.
- Decrease in lung function.
- Hospital admissions.
- Conflicting evidence negative studies in Europe
and Sydney.
29Sulphur Dioxide
- Soluble, irritant gas
- Product of burning sulphurous fossil fuel
- Only point source pollutant in Australia
30Effects of Sulphur Dioxide
- Potent trigger for bronchoconstriction in people
with asthma at 0.25 0.5 ppm - Individual variability in susceptibility
- Very brief exposure required
- Partially blocked by ipratropium and
indomethacin - No effect in people without asthma up to 5ppm
31- SO2 dose response relationship for symptoms in 23
people with mild asthma when exposed to arrange
of SO2 concentrations for 5 minutes. Plt0.05.
Total symptoms score is the aggregate of cough,
sputum, substernal irritation, wheeze, chest
tightness, dyspnea, throat irritation, nasal
discharge/congestion, fatigue, headache, eye
irritation and any other symptoms. From Linn et
al., 1983.
32SO2 dose response relationship for FEV1 in
non-asthmatics, mild and severe asthmatics when
exposed to arrange of SO2 concentrations for 15
minutes. 85 people including 24 non-atopic and
non-asthmatics, 21 atopics, 16 minimal/mild
asthmatics and 24 moderate/severe asthmatics.
(From Linn et al. 1987).
33Meta-analysis for SO2
- 0.01 ppm increase in SO2.
- Ambient 24 hour levels ranged from 0.004-0.04 ppm
- Hospitalisations of studies OR 95 CIs
- Total 25 1.0229 1.0140-1.0318
- Respiratory 10 1.0202 1.0103-1.0301
- Asthma 10 1.0299 1.0065-1.0538
- Cardiovascular 5 1.0265 1.0024-1.0512
- Mortality
- Total 16 1.0158 1.0066-1.0251
- Respiratory 14 1.0119 0.9994-1.0246
- Cardiovascular 12 1.0095 1.0022-1.0169
34Conclusion
- Varying relation to asthma
- Heterogeneity in response only partly (and
loosely) related to asthma status - Mechanisms not established
- Evidence that more than one may be involved
- Epidemiology is difficult
- Ubiquitous exposure
- Lots of confounders